Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO™

SAN DIEGO, May 20, 2016  -- Otonomy, Inc. (OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved transitional pass-through status and established a new billing code for OTIPRIO™ (ciprofloxacin otic suspension). The code, C9479, will become effective July 1, 2016.
 
“We welcome CMS’s decision to grant pass-through status and assign a new C code for OTIPRIO which can be used for billing in the hospital outpatient and ambulatory surgery center (ASC) settings,” said David A. Weber, Ph.D., president and CEO of Otonomy. “Furthermore, the timing of this assignment early in the launch of OTIPRIO will, we believe, be very helpful in our ongoing efforts to facilitate patient access.”
 
According to a CMS reference article, “C codes are unique temporary pricing codes that were initially established by CMS for the Hospital Outpatient Prospective Payment System (OPPS).
Read more: Otonomy Inc ( OTIC )

Terraco to Exercise Spring Valley Royalties and Enters Into US$19,030,000 Strategic Transaction

VANCOUVER, BRITISH COLUMBIA--(May 16, 2016) - Terraco Gold Corp. (TSX VENTURE:TEN)("Terraco" or the "Company") is pleased to announce that it has entered into definitive agreements with Solidus Resources, LLC, a wholly-owned subsidiary of Waterton Precious Metals Fund II Cayman, LP (collectively, "Waterton"), pursuant to which Waterton will acquire 100% of the Company's claims, leases, title and mineral rights proximate to Waterton's Spring Valley gold project in Pershing County, Nevada ("Spring Valley"), including the Company's Moonlight Project located adjacent to the north of Spring Valley but excluding certain royalties held by the Company, (collectively, the "SV Proximal Assets") in exchange for US$7,000,000 in cash (the "Cash Consideration") and a 2% NSR on the SV Proximal Assets (the "Asset Purchase"). Concurrently with the Asset Purchase, Waterton will subscribe for a senior unsecured convertible debenture in the aggregate principal amount of US$12,030,000 (the "Debenture") in TGC Holdings, Ltd. ("TGC Holdings"), a wholly-owned subsidiary of the Company, (the "Debenture Transaction" and together with the Asset Purchase, the "Transactions"). The Debenture will bear 0.05% (five hundredths of one percent) interest per annum, will have a term of five years and may be converted into either common shares of Terraco ("Terraco Shares") at a price of C$0.18 per share, representing a 57% premium to the Company's twenty-day volume weighted average price of $0.1149 as at May 13, 2016, or into shares of TGC Holdings ("TGC Shares").
Read more: Terraco Gold Corp ( TEN )

Oban Intersects 17.22 g/t Au Over 3.9 Metres at Windfall

TORONTO, ONTARIO--(May 12, 2016) - Oban Mining Corporation (OBM.TO) ("Oban" or the "Corporation") is pleased to announce new results from the ongoing drill program at its 100% owned Windfall Lake gold project located in Urban - Barry Townships, Québec. The 55,000 metre drill program combines definition drilling above the Red Dog intrusion ("Red Dog") and expansion drilling above and below Red Dog.
 
Highlights from 16 new drill holes include: 17.22 g/t Au over 3.9 metres in DDH OBM-16-642; 25.2 g/t Au over 2.3 metres in DDH OBM-16-643; 9.94 g/t Au over 5.3 metres in DDH OBM-16-651; and 9.55 g/t Au over 2.4 metres in DDH OBM-16-649. The new results continue to demonstrate lateral and vertical continuity of high grade gold mineralization in Zone 27 and the Caribou Zone, and also highlights new zones continuing to develop between these two major mineralized corridors. The table below outlines significant new results(1)(2):
Read more: Oban Mining Corporation ( OBM )

Histogenics Corporation Announces First Quarter 2016 Financial and Operating Results

- NeoCart® Phase 3 Clinical Trial Remains on Track for Enrollment Completion by End of Second Quarter of 2017 -
- Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT -
 
WALTHAM, Mass., May 12, 2016  -- Histogenics Corporation (Histogenics) (HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, announced its financial and operational results for the quarter ended March 31, 2016. 
 
“We made significant progress on a number of important business objectives in the first quarter of 2016. Most importantly, we continued the positive enrollment trends we have seen over the last several months in the NeoCart Phase 3 clinical trial and remain confident that we are on track to complete patient enrollment by the end of the second quarter of 2017,” stated Adam Gridley, President and Chief Executive Officer of Histogenics.
Read more: Histogenics Corporation ( Histogenics )

NexGen Energy Ltd. - Hole AR-16-76c1 Returns 67.5 m at 11.29% U3O8 including 9.0 m at 51.35% U3O8 and 0.5 m at 79.80% U3O8

VANCOUVER, May 5, 2016 NexGen Energy Ltd. ("NexGen" or the "Company") (TSXV:NXE, OTCQX:NXGEF) is pleased to report assay results for thirteen angled holes from our highly successful winter 2016 drilling program on our 100% owned, Rook I property, Athabasca Basin, Saskatchewan.
Hole AR-16-76c1 has intersected 67.5 m at 11.29% U3O8 in the higher grade A2 sub-zone (the "Sub-Zone"). The intercept includes 9.0 m at 51.35% U3O8 and 0.5 m at 79.80% U3O8 which represents a continuous grade x thickness ("GT") of 762, the second best at the Arrow Deposit to date. Drill hole -76c1 intercepted the near vertically dipping mineralization at a shallow inclination of -65°.   All five drill holes reported in this release and drilled into the Sub-Zone have returned strong and broad intercepts of high grade mineralization (as determined by a total composite GT of >200) confirming strong continuity of the High Grade Domain.
In addition, holes AR-16-63c3, AR-16-64c3, AR-16-72c2 and AR-16-74c1 all intersected high grade uranium mineralization in the Sub-Zone. Assay results from AR-16-72c2 were higher than anticipated from the radioactivity results, and as such, the hole is now being included within the Sub-Zone.  
Read more: NexGen Energy Ltd ( NXE )